Cargando…
Adverse events of intestinal microbiota transplantation in randomized controlled trials: a systematic review and meta-analysis
BACKGROUND: Intestinal microbiota transplantation (IMT) has been recognized as an effective treatment for recurrent Clostridium difficile infection (rCDI) and a novel treatment option for other diseases. However, the safety of IMT in patients has not been established. AIMS: This systematic review an...
Autores principales: | Chen, Chong, Chen, Liyu, Sun, Dayong, Li, Cailan, Xi, Shiheng, Ding, Shihua, Luo, Rongrong, Geng, Yan, Bai, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134705/ https://www.ncbi.nlm.nih.gov/pubmed/35619175 http://dx.doi.org/10.1186/s13099-022-00491-3 |
Ejemplares similares
-
Adverse events in fecal microbiota transplantation: a systematic review and meta-analysis
por: Rapoport, Eliot A., et al.
Publicado: (2022) -
Systematic Review: Adverse Events of Fecal Microbiota Transplantation
por: Wang, Sinan, et al.
Publicado: (2016) -
Adverse events of fecal microbiota transplantation: a meta-analysis of high-quality studies
por: Michailidis, Lamprinos, et al.
Publicado: (2021) -
Clinical‐radiological characteristics and intestinal microbiota in patients with pancreatic immune‐related adverse events
por: Tan, Bei, et al.
Publicado: (2021) -
Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
por: Zhou, Youlian, et al.
Publicado: (2019)